- Home
- DBI vs RZLT Comparison
DBI vs RZLT Comparison
Compare DBI & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- RZLT
- Stock Information
- Founded
- DBI 1991
- RZLT 2010
- Country
- DBI United States
- RZLT United States
- Employees
- DBI N/A
- RZLT N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- RZLT Health Care
- Exchange
- DBI Nasdaq
- RZLT Nasdaq
- Market Cap
- DBI 292.2M
- RZLT 292.0M
- IPO Year
- DBI 1991
- RZLT N/A
- Fundamental
- Price
- DBI $5.52
- RZLT $4.94
- Analyst Decision
- DBI Hold
- RZLT Strong Buy
- Analyst Count
- DBI 2
- RZLT 8
- Target Price
- DBI $5.75
- RZLT $11.63
- AVG Volume (30 Days)
- DBI 2.1M
- RZLT 373.9K
- Earning Date
- DBI 12-10-2024
- RZLT 02-11-2025
- Dividend Yield
- DBI 3.68%
- RZLT N/A
- EPS Growth
- DBI N/A
- RZLT N/A
- EPS
- DBI N/A
- RZLT N/A
- Revenue
- DBI $3,050,038,000.00
- RZLT N/A
- Revenue This Year
- DBI N/A
- RZLT N/A
- Revenue Next Year
- DBI $2.23
- RZLT N/A
- P/E Ratio
- DBI N/A
- RZLT N/A
- Revenue Growth
- DBI N/A
- RZLT N/A
- 52 Week Low
- DBI $4.36
- RZLT $0.88
- 52 Week High
- DBI $11.57
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- DBI 46.98
- RZLT 44.97
- Support Level
- DBI $5.18
- RZLT $4.07
- Resistance Level
- DBI $6.21
- RZLT $4.68
- Average True Range (ATR)
- DBI 0.43
- RZLT 0.33
- MACD
- DBI -0.05
- RZLT -0.01
- Stochastic Oscillator
- DBI 42.47
- RZLT 37.50
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.